Download PDF
Thromb Haemost 1991; 66(05): 565-568
DOI: 10.1055/s-0038-1646460
Original Article
Schattauer GmbH Stuttgart

Effects of Poloxamer 188 on the Assembly, Structure and Dissolution of Fibrin Clots

Marcus E Carr Jr.
1   The Coagulation Special Studies Laboratory, Departments of Medicine and Pathology, Medical College of Virginia, USA
2   The McGuire V. A. Medical Center Richmond, Virginia, USA
,
P L Powers
2   The McGuire V. A. Medical Center Richmond, Virginia, USA
,
Marsha R Jones
3   The Burroughs Wellcome Co., Research Triangle Park, NC, USA
› Author Affiliations
Further Information

Publication History

Received 18 December 1990

Accepted 24 April 1991

Publication Date:
25 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

Poloxamer 188, N.F. (RheothRx®), a nonionic block copolymer composed of 2 hydrophilic polyoxyethylene chains connected by a hydrophobic polyoxypropylene chain, normalizes the viscosity of whole blood high in soluble fibrin(ogen) complexes. Normalization may be via a poloxamer 188-induced decrease in fibrin(ogen)-red cell interaction. Our study examined the influences of poloxamer 188 on fibrin assembly and structure. Studies were performed in both purified and plasma systems with a poloxamer 188 concentration range of 0.1-20 mg/ml and specific clotting conditions (fibrinogen 1 mg/ml, thrombin 1 NIH u/ml, pH 7.4 [Tris 0.05 M], ionic strength 0.15 and calcium 5 mM). Fibrin assembly was accelerated in the presence of poloxamer 188. As poloxamer 188 concentration was increased from 0 to 8 mg/ml in plasma: a) the lag phase prior to initial turbidity rise decreased from 25 to <5 s; b) the final gel optical density (OD) increased from 0.65 to 1.28 and c) fiber size (mass/length ratio [ε]) increased from 4.3 to 12.6 × 1013 daltons/cm. Similar results were seen in the purified system with a poloxamer 188 concentration range of 0-8 mg/ml. OD increased from 0.26 to 0.51, and ε increased from 2.3 to 5.3 × 1013 daltons/cm. Above 8 mg/ml, precipitation of fibrinogen was noted in this system. Since large fibrin fibers tend to be degraded more rapidly, possible poloxamer mediated enhancement of r-tPA-mediated clot lysis was investigated. With r-tPA (70 lu/ml) present at the time of clotting, clot lysis in the presence of ploxamer 188 (8 mg/ml) was 50% complete at 1,600 s compared to 2,540 s for the control. Thus, poloxamer 188-induced alterations in fibrin structure and fibrin-cell interactions may explain some of this agent's interesting hemorrheologic and antithrombotic properties.

 

  • References

  • 1 Ferry JD, Morrison PR. Preparation and properties of serum and plasma proteins. VIII. The conversion of human fibrinogen to fibrin under various conditions. J Am Chem Soc 1947; 69: 388-99
    CrossrefPubMedGoogle Scholar
  • 2 Shulman S, Ferry JD, Tinoco I. The conversion of fibrinogen to fibrin. XII. Influence of pH, ionic strength and hexamethylene glycol concentration on the polymerization of fibrinogen. Arch Biochem Biophys 1953; 42: 245-56
    CrossrefPubMedGoogle Scholar
  • 3 Gabriel DA, Smith LA, Folds JD, Davis L, Cancelosi SE. The influence of immunoglobulin (IgG) on the assembly of fibrin gels. J Lab Clin Med 1983; 101: 545-52
    PubMedGoogle Scholar
  • 4 Bale MD, Westrick LG, Mosher DF. Incorporation of thrombospondin into fibrin clots. J Biol Chem 1985; 260: 7502-8
    PubMedGoogle Scholar
  • 5 Carr ME. Turbidimetric evaluation of albumin's impact on the structure of thrombin mediated fibrin gels. Haemostasis 1987; 17: 189-94
    PubMedGoogle Scholar
  • 6 Carr ME, Gabriel DA, McDonagh J. Influence of factor XIII and fibronectin on fiber size in thrombin-induced fibrin gels. J Lab Clin Med 1987; 110: 747-52
    PubMedGoogle Scholar
  • 7 Carr ME, Gabriel DA, Herion JC, Roberts HR. Granulocyte lysosomal cationic protein alters fibrin assembly: a possible mechanism for granulocyte control of clot structure. J Lab Clin Med 1986; 107: 199-203
    PubMedGoogle Scholar
  • 8 Carr ME, White GC, Gabriel DA. Platelet factor 4 enhances fibrin fiber polymerization. Thromb Res 1987; 45: 539-43
    CrossrefPubMedGoogle Scholar
  • 9 LeBoeuf RD, Gregg RR, Weigel PH, Fuller GM. Effects of hyalronic acid and other glycosaminoglycans on fibrin polymer formation. Biochemistry 1987; 26: 6052-7
    CrossrefPubMedGoogle Scholar
  • 10 Jones M, Gabriel DA. Influence of the subendothelial basement membrane components on fibrin assembly. Evidence for a fibrin binding site on Type IV collagen. J Biol Chem 1988; 263: 7043-8
    PubMedGoogle Scholar
  • 11 Carr ME, Powers PL. Effect of glycosaminoglycans on thrombin- and atroxin-induced fibrin assembly and structure. Thromb Haemostas 1989; 62: 1057-61
    PubMedGoogle Scholar
  • 12 Carr ME, Gabriel DA, McDonagh J. Influence of calcium on the structure of reptilase and thrombin derived fibrin gels. Biochem J 1986; 239: 513-6
    CrossrefPubMedGoogle Scholar
  • 13 Shen LL, Hermans J, McDonagh RP, Carr ME. Effects of calcium ion and covalent crosslinking on formation and elasticity of fibrin gels. Thromb Res 1975; 6: 255-65
    CrossrefPubMedGoogle Scholar
  • 14 Marx G. Divalent cations induce protofibril gelation. Am J Hematol 1988; 27: 104-9
    CrossrefPubMedGoogle Scholar
  • 15 Carr ME, Gabriel DA. The effect of dextran 70 on the structure of plasma-derived fibrin gels. J Lab Clin Med 1980; 96: 985-93
    PubMedGoogle Scholar
  • 16 Carr ME, Gabriel DA. Dextran-induced changes in fibrin fiber size and density based on wavelength dependence of gel turbidity. Macromolecules 1980; 13: 1473-7
    CrossrefPubMedGoogle Scholar
  • 17 Carr ME. The effect of hydroxyethyl starch on the structure of thrombin and reptilase induced fibrin gels. J Lab Clin Med 1986; 108: 556-63
    PubMedGoogle Scholar
  • 18 Carr ME, Hardin CL. Large fibrin fibers enhance urokinase-induced plasmin digestion of plasma clots. Blood 1987; 70 (Suppl 1) 400a
    PubMedGoogle Scholar
  • 19 Hunter RL, Papadea C, Gallagher CJ, Finlayson DC, Check IJ. Increased whole blood viscosity during coronary artery bypass surgery – studies to evaluate the effects of soluble fibrin and poloxamer 188. Thromb Haemostas 1990; 63: 6-12
    PubMedGoogle Scholar
  • 20 Colbassani HJ, Barrow DL, Sweeney KM, Bakay RAE, Check IJ, Hunter RL. Modification of acute focal ischemia in rabbits by poloxamer 188. Stroke 1989; 20: 1241-6
    CrossrefPubMedGoogle Scholar
  • 21 Robinson KA, Hunter RL, Stack JE, Hearn JA, Apiarian RP, Roubin GS. Inhibition of coronary arterial thrombosis in swine by infusion of Poloxamer 188. J Invest Cardiol 1990; 2: 9-20
    PubMedGoogle Scholar
  • 22 Hunter RL, Bennett B, Check IJ. The effect of Poloxamer 188 on the rate of in vitro thrombolysis mediated by t-PA and streptokinase. Fibrinolysis 1990; 4: 117-23
    PubMedGoogle Scholar
  • 23 Laki K. The polymerization of proteins: the action of thrombin on fibrinogen. Arch Biochem Biophys 1951; 32: 317-24
    CrossrefPubMedGoogle Scholar
  • 24 Clauss A. A rapid physiological coagulation method for determination of fibrinogen. Acta Haematol 1957; 17: 237-46
    CrossrefPubMedGoogle Scholar
  • 25 Carr ME, Hermans J. Size and density of fibrin fibers from turbidity. Macromolecules 1978; 11: 46-50
    CrossrefPubMedGoogle Scholar
  • 26 Carr ME, Krishnamurti C, Alving BM. Effect of plasminogen activator inhibitor type 1 (PAI-1) on tissue plasminogen activator (TPA) induced fibrinolysis. Blood 1988; 72: 293a
    PubMedGoogle Scholar
  • 27 Carr ME, Shen LL, Hermans J. Mass-length ratio of fibrin fibers from gel permeation and light scattering. Biopolymers 1977; 16: 1-15
    CrossrefPubMedGoogle Scholar
  • 28 Carr ME. Fibrin formed in plasma is composed of fibers more massive than those formed from purified fibrinogen. Thromb Haemostas 1988; 5 9(3) 535-9
    PubMedGoogle Scholar
  • 29 Carr ME, Hardin CL. Fibrin has larger pores when formed in the presence of erythrocytes. Am J Physiol 1987; 253: H1069-H1073
    PubMedGoogle Scholar
  • 30 Carr ME, Hauge Y. Enhancement of erythrocyte washout from blood clots by pharmacologic manipulation of gel pore size and erythrocyte flexibility. Am J Physiol (Heart) 1990 in press
    PubMedGoogle Scholar
  • 31 Carr ME, Powers PL. Effect of fibrin structure on t-PA induced dissolution of preformed plasma clots. Fibrinolysis 1990; 4 (Suppl 3) 124
    PubMedGoogle Scholar
  • 32 Hymes AC, Robb HJ, Margulis RR. Influence of an inductrial surfactant (pluronic F-68) on human amniotic fluid embolism. Am J Obstet Gynecol 1970; 107: 1217-22
    CrossrefPubMedGoogle Scholar
  • 33 Witte S, Dirnberger P. Wirkungen von Protamin auf Fibrinogen in vivo und in vitro. Klin Wochenschr 1952; 385: 997
    PubMedGoogle Scholar
  • 34 Cohen C, Slayter H, Goldstein L, Kucera J, Hall C. Polymorphism in fibrinogen aggregates. J Mol Biol 1966; 22: 385-6
    CrossrefPubMedGoogle Scholar
  • 35 Stewart GJ, Niewiarowski S. Nonenzymatic polymerization of fibrinogen by protamine sulfate. Biochim Biophys Acta 1969; 194: 462-9
    CrossrefPubMedGoogle Scholar